{
    "patient": {
        "Name": "Bryan Bishop",
        "DateOfBirth": "1985-09-14",
        "Sex": "Female",
        "Diagnosis": "Hodgkin lymphoma",
        "BodyPart": "Lymphoma",
        "Physician": "Dr. Laura Ballard",
        "TreatingInstitution": "Mcintosh, Garcia and Davis"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Lymphoma",
            "CollectedDate": "2023-07-16",
            "ReceivedDate": "2023-07-17",
            "TumorPercentage": "26%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-07-23",
            "ReceivedDate": "2023-07-23"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "MPL",
                "DNA Alteration": "c.1543_1545delinsAAA",
                "GeneMutation": "p.W515L Stopgain-LOF",
                "VariantAlleleFraction": "10.36%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.742C>T",
                "GeneMutation": "p.K132N Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.97%"
            },
            {
                "Gene": "ABL1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A34V Spliceregionvariant-GOF",
                "VariantAlleleFraction": "27.51%"
            },
            {
                "Gene": "BRCA2",
                "DNA Alteration": "c.5946delT",
                "GeneMutation": "p.S1982Rfs*22 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "1.82%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.S1982Rfs*22 Spliceregionvariant-LOF",
                "VariantAlleleFraction": "17.94%"
            },
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.S1982Rfs*22 Spliceregionvariant-LOF",
                "VariantAlleleFraction": "5.16%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "APC",
            "CCND3",
            "CALR"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "18 m/Mb",
            "Tmbpercentile": "23%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    },
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.K385fs*47 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "13.11%"
            },
            {
                "Gene": "FGFR4",
                "DNA Alteration": "c.1162G>A",
                "GeneMutation": "p.G388R Frameshift-LOF",
                "VariantAlleleFraction": "1.93%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.2310_2311ins9",
                "GeneMutation": "p.D770_N771insD Frameshift-LOF",
                "VariantAlleleFraction": "10.31%"
            },
            {
                "Gene": "PKLR",
                "DNA Alteration": "c.1436G>A",
                "GeneMutation": "p.R479H Nonsense-LOF",
                "VariantAlleleFraction": "3.76%"
            },
            {
                "Gene": "MYD88",
                "DNA Alteration": "c.794T>C",
                "GeneMutation": "p.L265P Nonsense-GOF",
                "VariantAlleleFraction": "3.63%"
            },
            {
                "Gene": "DICER1",
                "DNA Alteration": "c.5428G>C",
                "GeneMutation": "p.E1705V Frameshift-LOF",
                "VariantAlleleFraction": "3.55%"
            },
            {
                "Gene": "BRCA1",
                "DNA Alteration": "c.5265_5266insC",
                "GeneMutation": "p.Q1756Pfs Stopgain-LOF",
                "VariantAlleleFraction": "3.22%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5664C>A",
                "GeneMutation": "p.G1954R Nonsense-LOF",
                "VariantAlleleFraction": "7.15%"
            }
        ],
        "Germline": [
            {
                "Gene": "CHD6",
                "DNA Alteration": "c.4800C>G",
                "GeneMutation": "p.I1600M Spliceregionvariant-LOF",
                "Condition": "drive"
            }
        ]
    },
    "low coverage regions": [
        "CDKN2A"
    ],
    "genomic variants details": {
        "Somatic Variant Details - Potentially Actionable": [
            {
                "Gene": "MPL",
                "DNA Alteration": "c.1543_1545delinsAAA",
                "GeneMutation": "p.W515L Stopgain-LOF",
                "description": "TP53 encodes a protein that is a transcription factor that regulates the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. TP53 is a tumor suppressor gene that is mutated in many cancers. Mutations in TP53 are associated with cancer progression.",
                "VariantAlleleFraction": "10.36%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.742C>T",
                "GeneMutation": "p.K132N Spliceregionvariant-LOF",
                "description": "TP53 encodes a protein that is a transcription factor that regulates the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. TP53 is a tumor suppressor gene that is mutated in many cancers. Mutations in TP53 are associated with cancer progression.",
                "VariantAlleleFraction": "7.97%"
            },
            {
                "Gene": "ABL1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A34V Spliceregionvariant-GOF",
                "description": "PTEN encodes a phosphatase that acts as a tumor suppressor by negatively regulating the PI3K-AKT-mTOR pathway. Loss of function mutations, copy number loss, and underexpression of PTEN are associated with cancer progression.",
                "VariantAlleleFraction": "27.51%"
            },
            {
                "Gene": "BRCA2",
                "DNA Alteration": "c.5946delT",
                "GeneMutation": "p.S1982Rfs*22 Missensevariant(exon2)-GOF",
                "description": "TP53 encodes a protein that is a transcription factor that regulates the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. TP53 is a tumor suppressor gene that is mutated in many cancers. Mutations in TP53 are associated with cancer progression.",
                "VariantAlleleFraction": "1.82%"
            }
        ],
        "Somatic Variant Details - Biologically Relevant": [
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.S1982Rfs*22 Spliceregionvariant-LOF",
                "description": "KRAS is a GDP/GTP binding protein that acts as an intracellular signal transducer. KRAS is involved in several pathways involved in cellular proliferation and survival, including the PI3K-AKT-mTOR pathway and the Ras-Raf-MEK-ERK pathway. Activating mutations, copy number gains, and overexpression of KRAS are associated with cancer progression.",
                "VariantAlleleFraction": "17.94%"
            },
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.S1982Rfs*22 Spliceregionvariant-LOF",
                "description": "KRAS is a GDP/GTP binding protein that acts as an intracellular signal transducer. KRAS is involved in several pathways involved in cellular proliferation and survival, including the PI3K-AKT-mTOR pathway and the Ras-Raf-MEK-ERK pathway. Activating mutations, copy number gains, and overexpression of KRAS are associated with cancer progression.",
                "VariantAlleleFraction": "5.16%"
            }
        ]
    },
    "clinical history": {
        "Date": "2023-07-15"
    },
    "other": {
        "ReportId": "8371",
        "ReportDate": "2023-07-25",
        "SignedBy": "Laura Ballard",
        "Supervisor": "Dr. Anne Gibson"
    }
}